Evidence map›Paper›PMID 27807769›Full record

ArticleDrug delivery and translational research2016

Nanogels of methylcellulose hydrophobized with N-tert-butylacrylamide for ocular drug delivery.

Marion Jamard, Todd Hoare, Heather Sheardown

Abstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Micelle nanogel-based drug delivery system for lutein in ocular administration.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Alginate-International journal of molecular sciences · 2021
    Article
  11. Review
  12. Article
  13. Hydrogel Biomaterials for Application in Ocular Drug Delivery.Frontiers in bioengineering and biotechnology · 2020
    Review
  14. Review
  15. Article
  16. In vitro and ex vivo correlation of drug release from ophthalmic ointments.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marion JamardSchool of Biomedical Engineering, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S 4L8, Canada.
Todd HoareDepartment of Chemical Engineering, McMaster University, 1280 Main Street West, Hamilton, L8S 4L8, Canada.
Heather SheardownDepartment of Chemical Engineering, McMaster University, 1280 Main Street West, Hamilton, L8S 4L8, Canada. sheardow@mcmaster.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While eye drops account for the majority of ophthalmic formulation for drug delivery, their efficiency is limited by rapid pre-corneal loss. In this study, we investigate nanogel suspensions in order to improve the topical ocular therapy by reducing dosage and frequency of administration. We synthesized self-assembling nanogels of 140 nm by grafting side chains of poly(N-tert-butylacrylamide) (PNtBAm) on methylcellulose via cerium ammonium nitrate. Successful grafting of PNtBAm onto methylcellulose (MC) was confirmed by both NMR and ATR. Synthesized molecules (MC-g-PNtBAm) self-assembled in water driven by hydrophobic interaction of the grafted side chains creating colloid solutions. Materials were synthesized by changing feed ratios of acid, initiator and monomer in order to control the degree of hydrophobic modification. The nanogels were tested for different degrees of grafting. Viability studies performed with HCE cells testified to the biocompatibility of poly(N-tert-butylacrylamide) grafted methylcellulose nanogels. Dexamethasone was entrapped with an efficiency superior to 95 % and its release presented minimal burst phase. Diffusion of drug from the nanogels was found to be delayed by increasing the degree of grafting. The release profile of the entrapped compound from the MC-g-PNtBAm nanogels can thus be tuned by simply adjusting the degree of hydrophobic modification. MC-g-PNtBAm nanogels present promising properties for ocular drug delivery.

Indexed as

AcrylamidesAdministration, OphthalmicCells, CulturedCell SurvivalDexamethasoneDrug CarriersDrug LiberationEpithelial CellsGelsHumansHydrophobic and Hydrophilic InteractionsMethylcelluloseNanoparticlesAcrylamidesDexamethasoneDrug CarriersGelsMethylcellulosetert-butylacrylamideDrug delivery/releaseHydrophobizationMethylcelluloseNanogelsOphthalmicPolysaccharide

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.